Device Review Program Faces Organizational Changes; User Fees Coming?
This article was originally published in The Silver Sheet
NOVEL DEVICE PREMARKET REVIEW OPTIONS will be a primary focus of the Center for Devices and Radiological Health’s new office dedicated to in vitro diagnostic products. The IVD office will embody the device center’s "total product life cycle" approach to regulating products, which seeks to eliminate the division between premarket and postmarket activities. A new division devoted to cardiovascular devices, new leadership and the possibility of user fees are among the changes facing the CDRH’s Office of Device Evaluation. Meanwhile, ODE looks for ways to improve its expedited and modular PMA options and to encourage greater use of abbreviated 510(k)s and third parties
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.